Traditional and emerging antifungal therapies.
作者： T. M. Arnold , E. Dotson , G. A. Sarosi , C. A. Hage
DOI: 10.1513/PATS.200906-048AL
关键词: Population 、 Antifungal 、 Pharmacology 、 Invasive Mycoses 、 Intensive care medicine 、 Echinocandins 、 Biology 、 Drug 、 Adverse effect
摘要: Invasive mycoses continue to be a major problem in the growing population of immunosuppressed patients. More antifungal agents are now available than ever. The options many, with more efficacies and less toxicity past. These differ terms spectrum activity, pharmacologic properties, indications. In this article we discuss three classes agents: polyens, triazoles, echinocandins. emphasis is placed on their clinical use, side effects, drug interactions, other practical issues.
cabdirect.org
sci-hub.se 参考文章(71)
Andreas H. Groll, Stephen C. Piscitelli, Thomas J. Walsh, Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development Advances in pharmacology (San Diego). ,vol. 44, pp. 343- 500 ,(1998) , 10.1016/S1054-3589(08)60129-5
Rachel Courtney, David Wexler, Elaine Radwanski, Josephine Lim, Mark Laughlin, Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults. British Journal of Clinical Pharmacology. ,vol. 57, pp. 218- 222 ,(2003) , 10.1046/J.1365-2125.2003.01977.X
Susan M. Grant, Stephen P. Clissold, Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs. ,vol. 39, pp. 877- 916 ,(1990) , 10.2165/00003495-199039060-00006
Syed R Ahmad, Sarah J Singer, Brad G Leissa, Congestive heart failure associated with itraconazole. The Lancet. ,vol. 357, pp. 1766- 1767 ,(2001) , 10.1016/S0140-6736(00)04891-1
Jen-Tse Cheng, , Robert T. Witty, Roscoe R. Robinson, William E. Yarger, Barbara M. Kennedy, Amphotericin B nephrotoxicity: Increased renal resistance and tubule permeability Kidney International. ,vol. 22, pp. 626- 633 ,(1982) , 10.1038/KI.1982.221
Gregory Eschenauer, Daryl D DePestel, Peggy L Carver, Comparison of echinocandin antifungals Therapeutics and Clinical Risk Management. ,vol. 3, pp. 71- 97 ,(2007) , 10.2147/TCRM.2007.3.1.71
N. de Wet, A. L. Cuentas, J. Suleiman, E. Baraldi, E. F. Krantz, M. Della Negra, H. Diekmann-Berndt, A Randomized, Double-Blind, Parallel-Group, Dose-Response Study of Micafungin Compared with Fluconazole for the Treatment of Esophageal Candidiasis in HIV-Positive Patients Clinical Infectious Diseases. ,vol. 39, pp. 842- 849 ,(2004) , 10.1086/423377
I. M. Hann, R Herbrecht, M Aoun, S. Kvaloy, D. Catovsky, C. R. Pinkerton, S. A. Schey, F Jacobs, A. Oakhill, R. F. Stevens, P. J. Darbyshire, B. E. S. Gibson, H. G. Prentice, A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology. ,vol. 98, pp. 711- 718 ,(1997) , 10.1046/J.1365-2141.1997.2473063.X
Andrew J. Ullmann, Jeffrey H. Lipton, David H. Vesole, Pranatharthi Chandrasekar, Amelia Langston, Stefano R. Tarantolo, Hildegard Greinix, Wellington Morais de Azevedo, Vijay Reddy, Navdeep Boparai, Lisa Pedicone, Hernando Patino, Simon Durrant, Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease The New England Journal of Medicine. ,vol. 356, pp. 335- 347 ,(2007) , 10.1056/NEJMOA061098
Oliver A. Cornely, Johan Maertens, Drew J. Winston, John Perfect, Andrew J. Ullmann, Thomas J. Walsh, David Helfgott, Jerzy Holowiecki, Dick Stockelberg, Yeow-Tee Goh, Mario Petrini, Cathy Hardalo, Ramachandran Suresh, David Angulo-Gonzalez, Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia The New England Journal of Medicine. ,vol. 356, pp. 348- 359 ,(2007) , 10.1056/NEJMOA061094